Oana Herlea-Pana

Oana Herlea-Pana

Auto-generated profile, based on publicly available information

Oana Herlea-Pana

Department of Medicine, Division of Endocrinology, The University of Oklahoma Health Sciences Center

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
XYXiuying Yang
Xiuying Yang
DBDaniel Brobst
Daniel Brobst
WCWing Suen Chan
Wing Suen Chan
MTMargaret Chui Ling Tse
Margaret Chui Ling Tse
OHOana Herlea-Pana
Oana Herlea-Pana
Chi Bun ChanChi Bun Chan
Chi Bun Chan
BDNF produced by skeletal muscle in female mice enables switching of fuel sources during fasting.

17 April 2025 in eLife
Verified
Journal Article
Open access
DWDan Wu
Dan Wu
VEVenkateswararao Eeda
Venkateswararao Eeda
ZMZahra Maria
Zahra Maria
KRKOMAL RAWAL
KOMAL RAWAL
AWAudrey Wang
Audrey Wang
WWWeidong Wang
Weidong Wang
Overnutrition engenders the expansion of adipose tissue and the accumulation of immune cells, in particular, macrophages, in the adipose tissue, leading to chronic low-grade inflammation and insulin resistance. In obesity, several proinflammatory subpopulations of adipose tissue macrophages (ATMs) identified hitherto include the conventional ‘M1-like’ CD11C-expressing ATM and the newly discovered metabolically activated CD9-expressing ATM; however, the relationship among ATM subpopulations is unclear. The ER stress sensor inositol-requiring enzyme 1α (IRE1α) is activated in the adipocytes and immune cells under obesity. It is unknown whether targeting IRE1α is capable of reversing insulin resistance and obesity and modulating the metabolically activated ATMs. We report that pharmacological inhibition of IRE1α RNase significantly ameliorates insulin resistance and glucose intolerance in male mice with diet-induced obesity. IRE1α inhibition also increases thermogenesis and energy expenditure, and hence protects against high fat diet-induced obesity. Our study shows that the ‘M1-like’ CD11c+ ATMs are largely overlapping with but yet non-identical to CD9+ ATMs in obese white adipose tissue. Notably, IRE1α inhibition diminishes the accumulation of obesity-induced metabolically activated ATMs and ‘M1-like’ ATMs, resulting in the curtailment of adipose inflammation and ensuing reactivation of thermogenesis, without augmentation of the alternatively activated M2 macrophage population. Our findings suggest the potential of targeting IRE1α for the therapeutic treatment of insulin resistance and obesity.